Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Progesterone for Repeated Implantation Failure
NCT06005207Recruiting
- Sponsor
- Nanjing University
- Start
- Aug 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of Crinone in Repeated Implantation Failure (RIF) (2 arms), sponsored by Nanjing University. Primary endpoint: Embryo implantation rate at 45 days. Started Aug 2023; status: recruiting.
02
Drugs
Crinone
03
Conditions
Repeated Implantation Failure (RIF)
Beyond the preview
Go deeper on NCT06005207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06005207.